What is Thymosin Alpha-1
Global Peptide Sciences supplies thymosin alpha-1 to laboratories across Australia, supporting studies into immune signalling, T-cell biology and inflammatory pathway research.
Thymosin alpha-1 (Tα1) is a naturally occurring 28-amino acid peptide first isolated from thymic extracts. It is N-terminally acetylated and derived from the larger precursor prothymosin alpha. Its synthetic form, thymalfasin, holds regulatory approvals in some other countries, but those approvals belong to that regulated product and do not extend to research material.
Each batch is produced under controlled manufacturing conditions and undergoes independent laboratory verification, supporting consistent, repeatable results across analytical testing. A Certificate of Analysis is available on request for every order.
What Is Thymosin Alpha-1?
Many researchers ask what thymosin alpha 1 is and why it appears so often in immunology literature, given how long it has been studied.
In laboratory models, Tα1 is examined for its role in T-cell maturation and for signalling through Toll-like receptors, particularly TLR9 on dendritic cells, which can shape T helper responses and natural killer cell activity. It has also been linked to regulatory T cells that produce IL-10, which is why researchers study it as a modulator of both innate and adaptive immune signalling rather than a simple immune stimulant.
Thymosin Alpha-1 Benefits Explored in Research
Within controlled laboratory settings, thymosin alpha 1 benefits are commonly explored in studies of:
- T-cell maturation and immune system regulation
- Innate and adaptive immune signalling
- Toll-like receptor and dendritic cell pathways
- Cytokine balance and inflammatory pathway modulation
- Antiviral immune response models
- Immune recovery and resilience models
These points reflect laboratory observation only and are not intended as claims about therapeutic outcomes. Clinical findings are mixed: a large Phase 3 sepsis trial (TESTS, BMJ, 2025) found no 28-day mortality benefit.
Research Areas of Interest
- Studies into T-cell development and immune modulation
- Investigation of Toll-like receptor signalling in dendritic cells
- Inflammation and cytokine signalling models
- Immune ageing and immune resilience research
Product Information
- Compound: Thymosin Alpha-1 (Tα1)
- Classification: Immunomodulatory peptide, thymic origin
- Length: 28 amino acids
- Molecular formula: C129H215N33O55 (approximately 3108.3 g/mol)
- Form: Lyophilised powder (white)
- Purity level: 98% or above (HPLC verified)
- Testing: Independent third-party laboratory verification, CoA available on request
- Storage: Store dry at -20°C for long-term storage
- Quantity: 10 mg per vial
Thymosin Alpha-1 Reconstitution
Researchers reconstituting thymosin alpha-1 for laboratory use typically follow standard laboratory protocols for combining lyophilised peptides with an appropriate sterile diluent prior to further analytical handling. Global Peptide Sciences does not provide reconstitution instructions intended for self-administration, and all reconstitution should be carried out in accordance with your own laboratory’s established procedures and safety documentation.
Why Researchers Study Thymosin Alpha-1
Laboratories examining immune function frequently reference thymosin alpha-1 because it is one of the most clinically examined thymic peptides, with a long record in hepatitis, vaccine-response and sepsis research, alongside a well-defined 28-residue sequence suited to batch-verified studies. That clinical record is uneven, so researchers weigh each model and endpoint separately and keep laboratory findings distinct from clinical outcomes.
Researchers comparing related immune and repair research compounds can explore the healing and recovery research category or read the Thymosin Alpha-1 research summary for a compound-specific overview.
Buy Thymosin Alpha-1 in Australia
Researchers looking to buy thymosin alpha 1 can access verified, batch-tested material through Global Peptide Sciences, with independent Certificates of Analysis available for every order.
Laboratories searching for thymosin alpha 1 Australia, or comparing options to buy thymosin alpha 1 peptide for a specific study design, can rely on a consistent supply chain backed by HPLC or LC-MS verification as reported by the testing laboratory. Researchers can review the batch report first, checking the compound name, batch number and method, and keeping purity data separate from identity data.
Global Peptide Sciences offers consistent quality control at every stage of supply, and researchers can browse the full catalogue to view other research compounds available alongside thymosin alpha-1.
Research Use Only
This compound is supplied strictly for laboratory research use and is not approved for human or animal consumption.
Research Applications
Research Applications
Thymosin Alpha-1 is used as a research compound to study:
T-cell differentiation and immune activation pathways
Innate and adaptive immune response mechanisms
Inflammation and cytokine modulation
Antiviral immune responses
Recovery and immune system balance
Previous Research Dosages Used
Typical research dosage range: 1.6–3mg administered twice weekly
Common study duration: 4–12 weeks
These dosage references are based on experimental and preclinical research contexts.
Certificate of Analysis
Chemical Structure
Molecular FormulaC₁₂₉H₂₁₅N₃₃O₅₅
Molecular Weight~3108.3 g/mol
Purity≥99%
AppearanceWhite Lyophilized Powder
StorageStore at -20°C
FormLyophilized Peptide Compound
Key Structural Characteristics
- 28-amino acid immunomodulatory peptide
- Derived from thymic hormones
- Supports T-cell activation and immune signaling
- Widely used in immune and inflammation research